Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
    • Transcripts
  • inderesTV
  • Portfolio
  • Forum
  • Premium
  • Femme
  • Nora AI
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team
Regulatory press release

Hynion AS - Restructuring Update

Hynion
Hynion AS ("Hynion" or the "Company") is currently undergoing a balance sheet
restructuring
with the objective of securing continuity and safeguarding value for the
Company's creditors
and shareholders, respectively. The restructuring process is nearing completion,
with a
successful outcome dependent on the achievement of a limited number of remaining
milestones.

From the outset, the restructuring effort has been supported by the Company's
creditors, and
all costs associated with the execution of the process have been funded by a
third-party
investor in order to avoid any preferential treatment among creditors, given the
inherent
bankruptcy risk.

As of today, Hynion and a third-party investor supportive of the restructuring
initiative have
reached conditional agreements with a total of 15 creditors in Hynion.
Restructuring status:

o Approximately NOK 6.75 million of debt converted to equity through Tranche 1
and 2
of the previously announced share issuances.

o Approximately NOK 9.8 million of remaining debt, of which the majority has
entered
into conditional debt sale agreements with a supportive third-party investor.
The
Company has not yet reached an agreement with Eminova Fondkommission AB
regarding a claim of approximately SEK 2.7 million.

o Approximately NOK 15.5 million in legal exposure related to a parent company
guarantee originating from Hynion Sverige AB. Hynion is ranked pari passu with
four
private individuals, settlement negotiations between the parties are ongoing.

o A framework has been established with an industrial counterparty for the sale
of the
Company's Hydrogen fueling asset in Porsgrunn for an undisclosed sum.

Timeline going forward:
Given the urgent timeline and the need to ensure fiscal and regulatory
compliance, the Board
of Directors in Hynion will convene on Wednesday, 14 January at 18:00 CET to
determine
whether a holistic restructuring package is feasible. The Board will continue
its dialogue with
Eminova Fondkommission AB, the Company's legal counterparty in Sweden, and
remaining
creditors with the objective of avoiding bankruptcy.

For further information please contact:

Lavrans Grjotheim, CEO

Phone: +47 400 49 141

This information is considered inside information pursuant to the EU Market
Abuse
Regulation and is subject to the disclosure requirements under section 5-12 of
the
Norwegian Securities Trading Act.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.